Adamis CEO Dr. Dennis J. Carlo to Present at the LD Micro Invitational Conference Today
04 Junio 2014 - 1:40PM
Marketwired
Adamis CEO Dr. Dennis J. Carlo to Present at the LD Micro
Invitational Conference Today
SAN DIEGO, CA--(Marketwired - Jun 4, 2014) - Adamis
Pharmaceuticals Corporation (NASDAQ: ADMP) announced it will
present at the LD Micro Invitational Conference today at the Luxe
Sunset Boulevard Hotel in Los Angeles.
The Company's presentation by Dr. Dennis Carlo, President and
CEO, will begin at 11:00 a.m. PDT. Dr. Carlo will provide an
update on the Company's specialty pharmaceutical programs including
its recently filed NDA for epinephrine injection.
About LD Mirco
LD Micro is a newsletter firm that focuses on finding
undervalued companies in the mirco-cap space. The conference
hosts 100 companies and provides them with the opportunity to
showcase to quality private and institutional investors. For
more information on the conference please visit ldmicro.com.
About Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation is a specialty
biopharmaceutical company focused on developing and commercializing
products in the therapeutic areas of respiratory disease, allergy,
oncology and immunology. The company's current specialty
pharmaceutical product candidates include the Epinephrine Injection
PFS syringe product for use in the emergency treatment of
anaphylaxis, APC-1000 and APC-5000 for the treatment of asthma and
chronic obstructive pulmonary disease, and APC-3000, an HFA inhaled
nasal steroid product for the treatment of allergic rhinitis. The
company's vaccine product candidates and cancer drug product
candidates under research and development include TeloB-VAX, a
cell-based therapeutic cancer vaccine and three drugs, APC-100,
APC-200, and APC-300, for the treatment of prostate cancer.
CONTACT: Mark Flather Director, Investor Relations &
Corporate Communications Adamis Pharmaceuticals Corporation (858)
412-7951 mflather@adamispharma.com
Adamis Pharmaceuticals (NASDAQ:ADMP)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Adamis Pharmaceuticals (NASDAQ:ADMP)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024
Real-Time news about Adamis Pharmaceuticals Corporation (NASDAQ): 0 recent articles
Más de Adamis Pharmaceuticals Corp. (MM) Artículos de Noticias